Catalent | Üzemi Eredmény

Operating Profit változás Dátum
Agilent USD 384M 24M 2023-12
AstraZeneca USD 1.95B 502M 2023-09
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Bruker USD 247.6M 123.1M 2023-12
Catalent USD -112000000 614M 2023-12
Centene USD 735M 436M 2023-09
Charles River Laboratories USD 132.92M 18.58M 2023-12
Cigna USD 2.22B 2M 2023-09
Danaher USD 1.34B 101M 2023-12
Dentsply International USD 73M 309M 2023-12
Eli Lilly USD 2.39B 1.94B 2023-12
Hologic USD 198.2M 65.7M 2023-12
Humana USD -348000000 1.55B 2023-12
Illumina USD -164000000 590M 2023-12
IQVIA Holdings USD 495M 14M 2023-12
Laboratory Of America USD -122800000 375.1M 2023-12
Lonza CHF 540M 356M 2023-06
McKesson USD 951M 149M 2023-09
Merck EUR 983M 14M 2023-09
Merck USD -1933000000 7.68B 2023-12
Mettler Toledo International USD 232.56M 18.6M 2023-12
Pfizer USD -6551000000 3.61B 2023-12
Quest Diagnostics USD 267M 75M 2023-12
Repligen USD -13563000 18.37M 2023-12
Revvity USD 77.16M 7.93M 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Supernus Pharmaceuticals USD -996000 9.13M 2023-12
Thermo Fisher Scientific USD 1.85B 10M 2023-12
Veradigm USD 25M 30.36M 2022-09
Waters USD 179.43M 20.43M 2023-09
West Pharmaceutical Services USD 160.9M 16.4M 2023-12



Catalent Üzemi Eredmény - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Apr 2024.